WASHINGTON, Oct. 13 (UPI) -- The U.S. Food and Drug Administration ordered four companies Tuesday to stop marketing codeine sulfate tablets that have not received FDA approval.

WASHINGTON, Oct. 1 (UPI) -- The U.S. Food and Drug Administration says it has issued the first draft guidance for industry on risk evaluation and mitigation strategies.

WASHINGTON, Sept. 3 (UPI) -- The U.S. Food and Drug Administration says it has determined most producers of drugs and biologics are generally meeting their regulatory obligations.

WASHINGTON, Aug. 12 (UPI) -- A California complaint has led to a conflict-of-interest investigation involving the head of U.S. drug approvals, the Food and Drug Administration confirms.

WASHINGTON, July 1 (UPI) -- The U.S. Food and Drug Administration announced Wednesday it will require a boxed warning for the smoking cessation drugs Chantix and Zyban.

WASHINGTON, June 25 (UPI) -- The U.S. Food and Drug Administration says U.S. marshals have seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. in Michigan.

WASHINGTON, June 16 (UPI) -- The U.S. Food and Drug Administration is urging people to stop using three Zicam-brand products marketed as cold remedies because of a health hazard.

WASHINGTON, June 15 (UPI) -- The U.S. Food and Drug Administration says there may be a link between the use of ADHD drugs and sudden cardiac death in healthy children.

WASHINGTON, June 1 (UPI) -- The U.S. Food and Drug Administration announced advancements in the understanding of the genetic basis for drug-inducted liver injury.